Correlation Between Eledon Pharmaceuticals and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eledon Pharmaceuticals and Atea Pharmaceuticals, you can compare the effects of market volatilities on Eledon Pharmaceuticals and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and Atea Pharmaceuticals.
Diversification Opportunities for Eledon Pharmaceuticals and Atea Pharmaceuticals
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Eledon and Atea is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eledon Pharmaceuticals and Atea Pharmaceuticals
Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to generate 1.65 times more return on investment than Atea Pharmaceuticals. However, Eledon Pharmaceuticals is 1.65 times more volatile than Atea Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Atea Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 247.00 in Eledon Pharmaceuticals on January 7, 2025 and sell it today you would earn a total of 36.00 from holding Eledon Pharmaceuticals or generate 14.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eledon Pharmaceuticals vs. Atea Pharmaceuticals
Performance |
| Timeline |
| Eledon Pharmaceuticals |
| Atea Pharmaceuticals |
Eledon Pharmaceuticals and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eledon Pharmaceuticals and Atea Pharmaceuticals
The main advantage of trading using opposite Eledon Pharmaceuticals and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eledon Pharmaceuticals position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.| Eledon Pharmaceuticals vs. Inozyme Pharma | Eledon Pharmaceuticals vs. Day One Biopharmaceuticals | Eledon Pharmaceuticals vs. Terns Pharmaceuticals | Eledon Pharmaceuticals vs. Hookipa Pharma |
| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |